2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$104.16+$5.55 (+5.63%)
Price as of Jun 23, 2026 7:33 PM EDT- $21.4BMarket Cap
- -6.46%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$104.16+$5.55 (+5.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 606.4M +66.73% | 363.7M +19.17% | 305.2M +24.39% | 245.4M +30.19% | |
Cost of Revenue | 122.9M +43.38% | 85.7M +30.76% | 65.6M +18.95% | 55.1M +24.86% | |
Gross Profit | 483.5M +73.94% | 278.0M +16.00% | 239.6M +25.97% | 190.2M +31.82% | |
Sales and Marketing Expense | 701.2M +52.06% | 461.1M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -771.1M +28.87% | -598.4M +4.79% | -571.0M +43.64% | -397.5M +45.75% | |
Depreciation and Amortization Expense | 6.0M +18.78% | 5.1M 0.00% | 5.1M -0.02% | 5.1M +0.02% | |
Total Operating Expenses | 1.9B +49.22% | 1.2B +22.38% | 1.0B +44.42% | 702.7M +24.69% | |
Operating Profit | -1.2B +41.96% | -878.3M +23.76% | -709.6M +55.17% | -457.3M +21.92% | |
Interest Income | 60.7M +13.79% | 53.3M +26.52% | 42.1M +280.22% | 11.1M +6,268.39% | |
Interest Expense | -83.8M -1.32% | -84.9M +3.94% | -81.7M +208.91% | -26.4M -34.66% | |
Interest Income and Expense and Net | -23.1M -26.79% | -31.6M -20.11% | -39.6M +157.48% | -15.4M -61.87% | |
Total Nonoperating Income and Expense | -1.8M -6,448.28% | 29,000 -98.44% | 1.9M +131.25% | -5.9M +78.35% | |
Income before Taxes | -1.3B +39.74% | -910.1M +21.83% | -747.0M +55.58% | -480.2M +10.02% | |
Income Taxes | 5.0M +35.58% | 3.7M +45.09% | 2.6M +84.74% | 1.4M +178.67% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.3B +39.73% | -913.8M +21.91% | -749.6M +55.66% | -481.5M +10.79% | |
Net Income from Continuing Operations Applicable to Common | -1.3B +39.73% | -913.8M +21.91% | -749.6M +55.66% | -481.5M +10.79% | |
Basic EPS and Net Income | -6.42 +15.26% | -5.57 +4.31% | -5.34 +36.57% | -3.91 +0.77% | |
Diluted EPS and Net Income | -6.42 +15.26% | -5.57 +4.31% | -5.34 +36.57% | -3.91 +0.77% | |
Basic Weighted Average Shares | 199.0M +21.32% | 164.0M +16.81% | 140.4M +14.14% | 123.0M +9.74% | |
Diluted Weighted Average Shares | 199.0M +21.32% | 164.0M +16.81% | 140.4M +14.14% | 123.0M +9.74% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 510.4M -8.03% | 555.0M +15.06% | 482.4M -55.09% | 1.1B +49.84% | |
Short-Term Investments | 919.6M +4.64% | 878.8M +194.83% | 298.1M +301.48% | 74.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.4B -0.26% | 1.4B +83.72% | 780.4M -32.03% | 1.1B +60.20% | |
Total Current Assets | 1.8B +10.64% | 1.6B +74.55% | 929.1M -27.04% | 1.3B +52.13% | |
Accumulated Depreciation | 60.8M +20.77% | 50.3M +12.72% | 44.6M +13.14% | 39.4M +6.43% | |
Property and Plant and Equipment and Net | 102.9M +28.59% | 80.1M +22.43% | 65.4M +15.74% | 56.5M +6.68% | |
Total Long-Term Assets | 97.4M +4.45% | 93.2M -3.47% | 96.6M +26.90% | 76.1M +49.25% | |
Total Assets | 2.3B +11.82% | 2.0B +52.29% | 1.3B -19.72% | 1.7B +33.21% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 468.9M +57.59% | 297.5M +31.87% | 225.6M +18.60% | 190.2M +40.75% | |
Total Long-Term Debt | 541.0M -50.97% | 1.1B -4.49% | 1.2B +2.67% | 1.1B +98.60% | |
Total Long-Term Liabilities | 5.6M +1,031.46% | 499,000 -84.13% | 3.1M -66.50% | 9.4M -53.24% | |
Total Liabilities | 1.5B -12.32% | 1.7B +4.70% | 1.7B +5.95% | 1.6B +88.28% | |
Retained Earnings | -5.6B +29.28% | -4.4B +26.52% | -3.4B +27.80% | -2.7B +19.04% | |
Total Stockholders Equity | 739.0M +158.95% | 285.4M +185.98% | -331.9M -477.40% | 88.0M -78.57% | |
Total Shares Outstanding | 214.3M +19.44% | 179.4M +21.22% | 148.0M +9.09% | 135.7M +14.25% | |
Cash Flow | |||||
Cash from Operating Activities | -935.0M +36.72% | -683.9M +27.53% | -536.2M +33.91% | -400.4M +10.22% | |
Capital Expenditures | 32.6M +48.52% | 21.9M +64.98% | 13.3M +34.52% | 9.9M +35.52% | |
Cash from Investing Activities | -64.6M -88.93% | -583.2M +160.81% | -223.6M +546.55% | -34.6M -46.20% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 954.1M -28.85% | 1.3B +696.15% | 168.4M -78.77% | 793.3M +29.50% | |
Financials Ratio | |||||
Gross Margin | 79.73% +4.32% | 76.43% -2.66% | 78.52% +1.27% | 77.53% +1.25% | |
Operating Margin | -205.59% -14.86% | -241.47% +3.86% | -232.51% +24.74% | -186.39% -6.35% | |
Return on Assets | -59.53% +9.28% | -54.47% +8.51% | -50.20% +51.16% | -33.21% -22.08% | |
Return on Equity | -249.28% -106.35% | 3,926.49% +539.00% | 614.47% +418.01% | -193.22% +52.56% | |
Revenue Growth | 66.73% +248.17% | 19.17% -21.42% | 24.39% -19.20% | 30.19% +106.41% | |
Current Ratio | 3.83 -29.79% | 5.45 +32.37% | 4.12 -38.48% | 6.69 +8.09% | |
Cash Ratio | 1.09 -41.64% | 1.87 -12.74% | 2.14 -62.13% | 5.65 +6.46% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow